Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
25 results
D2.63 - Airborne allergic contact dermatitis in a textile worker: role of formaldehyde and methylisothiazolinones
D2.64 - Occupational allergic contact dermatitis due to rubber additives: clinical features and occupational implications
D2.72 - Radiological heterogeneity and inflammatory phenotypes in allergic bronchopulmonary aspergillosis
D2.58 - Nickel Sensitization and Reversible Airway Dysfunction: Evidence from Pulmonary Function Response to Nickel Avoidance
D2.59 - Refining Quality of Life Assessment in CSU: Validation and Threshold Determination of the CU-Q2oL questionnaire
D2.61 - Allergic Contact Dermatitis Due to Disperse Textile Dyes: A 10-Year Review
D2.62 - Atypical Chronic Cheilitis as Manifestation of Atopic Dermatitis: A Diagnostic Dilemma
D2.65 - Allergic cheilitis related to vaginal lubricant: a case report
D2.66 - Allergic contact dermatitis to cobalt and concomitant sensitization to nickel and chromium
D2.67 - Clinical Profile of Allergic Contact Dermatitis in Workers and Factors Associated with Occupational Outcomes
D2.449 - Patients with Inadequately Controlled CRSwNP and Blood Eosinophil Count ≥150 cells/µL Experience Benefit with Depemokimab: An Analysis of Data from the Integrated ANCHOR-1/-2 Studies
D2.447 - Phenotyping of Chronic T2 Inflammatory Diseases of the Nose and Paranasal Sinuses and the Algorithm for Biologic Therapy Selection
D2.448 - Recommendations on Patient Education for Biological Therapy in CRSwNP – An EAACI Position Paper
D2.452 - Real-World Trends in the Epidemiology and Burden of Chronic Rhinosinusitis with Nasal Polyps Over Time in Germany Reveal Increasing Prevalence and Low Biologic Use
D2.455 - Does Biological Therapy Modify NSAID Hypersensitivity? Experience with Omalizumab and Mepolizumab in Patients with Asthma and Nasal Polyps with N-ERD
D2.456 - Chronic sinusitis with nasal polyposis: Add-on aspirin desensitization useful in dupilumab therapy?
D2.461 - Endothelial related miRs are dysregulated in C1-INH Angioedema patients: new potential biomarkers and therapeutic targets
D2.462 - Safety and predictors of tolerance in rituximab hypersensitivity management
D3.308 - Kounis Syndrome: the allergic myocardial infarction
D3.313 - Recurrent Anaphylaxis with Elevated Baseline Tryptase Revealing Hereditary Alpha-Tryptasemia with Mast Cell Activation
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download